Specification of Drug Substances and Products: Development and Validation of Analytical Methods (Record no. 101185)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00728 a2200193 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 151231b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780080983509 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.19 |
| Item number | SPE |
| 245 ## - TITLE STATEMENT | |
| Title | Specification of Drug Substances and Products: Development and Validation of Analytical Methods |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Amsterdam |
| Name of publisher, distributor, etc | Elsevier |
| Date of publication, distribution, etc | 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 380p |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Drugs Analysis |
| 9 (RLIN) | 371 |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Drugs Standards |
| 9 (RLIN) | 375 |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Drug development |
| 9 (RLIN) | 372 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riley, Christopher M. |
| 9 (RLIN) | 376 |
| Relator term | Editor |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosanske, Thomas W. |
| 9 (RLIN) | 377 |
| Relator term | Editor |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabel Riley, Shelley R. |
| Relator term | Editor |
| 9 (RLIN) | 102621 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Item type | Book |
| Call number prefix | 615.19 |
| Call number suffix | SPE |
No items available.